Skip to content

Effects of bilberry extract-containing dietary supplement on eye fatigue in VDT workers : double-blind, randomized, placebo controlled trial

Effects of bilberry extract-containing dietary supplement on eye fatigue in VDT workers : double-blind, randomized, placebo controlled trial - Effects of bilberry extract on eye fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008766
Enrollment
80
Registered
2012-08-24
Start date
2012-08-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye fatigue, dry eye

Interventions

Dietary supplement containing bilberry extract Placebo without containing bilberry extract

Sponsors

ShinYokohama shinoharaguchi orthopedic surgery/ dermatology, Medical Corporation Jico-kai Yagi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Workers using visual display terminal 2) Subjects with subjective eye fatigue 3) Subjects with lowered critical flicker frequency and lowered near point distance

Exclusion criteria

Exclusion criteria: 1) Corrected visual acuity < 1.0 2) High myopia 3) Routine use of bilberry extract, -enriched food or medicines with visual function-improving activity 4) Ophthalmic disorder and/or a history of severe ophthalmic disorder 5) Strabismus 6) Previous visual dysfunction due to cataract (congenital, senile, diabetic, complicated or traumatic) or glaucoma (chronic, acute, congenital, secondary) 7) A risk for developing pollinosis between July and December 8) Under medical treatment, or a history serious disease needing medical treatment 9) Lasik operation undergone within 3 month 10) Allergy to study diet 11) Participation in other clinical trial within a month 12) Expecting a pregnancy or lactation during the study period 13) Judged as unsuitable for the study based on the results of questionnaire 14) Judged to be excluded from the study by the investigator

Design outcomes

Primary

MeasureTime frame
Critical flicker frequency, near point distance (amplitude of accommodation)

Secondary

MeasureTime frame
Contrast sensitivity, functional visual acuity, BUT, keratconjunctival disorder, amount of lacrimal fluid storage (strip meniscometry), questionnaire

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026